当前位置:首页 - 行情中心 - 回盛生物(300871) - 财务分析 - 现金流量表

回盛生物

(300871)

  

流通市值:43.73亿  总市值:43.73亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金703,787,770.86345,560,420.551,308,078,441.82946,899,543.93
  收到的税费返还1,152,199.51982,083.4210,765,600.178,262,739.3
  收到其他与经营活动有关的现金60,086,873.1223,831,109.0783,790,485.336,422,655.3
  经营活动现金流入小计765,026,843.49370,373,613.041,402,634,527.29991,584,938.53
  购买商品、接受劳务支付的现金406,279,308.57195,358,121.66777,275,720.96574,022,892.15
  支付给职工以及为职工支付的现金95,594,928.8554,610,564.16149,028,972.3110,923,067.29
  支付的各项税费63,066,507.3626,927,525.684,533,881.355,831,743.9
  支付其他与经营活动有关的现金71,815,539.2540,857,102.92153,347,555.7369,292,174.44
  经营活动现金流出小计636,756,284.03317,753,314.341,164,186,130.29810,069,877.78
  经营活动产生的现金流量净额128,270,559.4652,620,298.7238,448,397181,515,060.75
二、投资活动产生的现金流量:
  收回投资收到的现金348,630,928.63132,961,200649,606,605.64489,274,905.64
  取得投资收益收到的现金2,038,043.061,401,730.487,100,045.125,040,367.33
  处置固定资产、无形资产和其他长期资产收回的现金净额17,609,872.46-397,577.82380,000
  处置子公司及其他营业单位收到的现金净额-71,257.46-71,257.46--
  投资活动现金流入小计368,207,586.69134,291,673.02657,104,228.58494,695,272.97
  购建固定资产、无形资产和其他长期资产支付的现金234,633,482.5970,847,142.9496,919,488.270,454,855.77
  投资支付的现金417,745,299.85192,519,400615,025,416.26568,190,500
  取得子公司及其他营业单位支付的现金---1,146,800.35
  投资活动现金流出小计652,378,782.44263,366,542.94711,944,904.46639,792,156.12
  投资活动产生的现金流量净额-284,171,195.75-129,074,869.92-54,840,675.88-145,096,883.15
三、筹资活动产生的现金流量:
  吸收投资收到的现金--375,0003,106,705.85
  其中:子公司吸收少数股东投资收到的现金--375,0003,106,705.85
  取得借款收到的现金424,250,000199,950,000220,000,000190,000,000
  收到其他与筹资活动有关的现金26,839,79612,680,10238,449,13234,251,984
  筹资活动现金流入小计451,089,796212,630,102258,824,132227,358,689.85
  偿还债务支付的现金210,000,00094,000,000368,075,007.66246,074,853.92
  分配股利、利润或偿付利息支付的现金4,098,780.741,459,849.9749,919,954.4648,388,903.16
  其中:子公司支付给少数股东的股利、利润724,662.08---
  支付其他与筹资活动有关的现金29,582,91867,2001,067,928.3947,600
  筹资活动现金流出小计243,681,698.7495,527,049.97419,062,890.42295,411,357.08
  筹资活动产生的现金流量净额207,408,097.26117,103,052.03-160,238,758.42-68,052,667.23
四、汇率变动对现金及现金等价物的影响-1,073,785.09-881,004.09-1,837,642.35-130,204.92
五、现金及现金等价物净增加额50,433,675.8839,767,476.7221,531,320.35-31,764,694.55
  加:期初现金及现金等价物余额206,123,263.59206,123,263.59184,591,943.24184,591,943.24
  期末现金及现金等价物余额256,556,939.47245,890,740.31206,123,263.59152,827,248.69
补充资料:
  净利润206,442,070.79-253,488,650.71-
  资产减值准备6,726,375.29-8,949,906.1-
  固定资产和投资性房地产折旧61,164,000.72-116,997,069.72-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧61,164,000.72-116,997,069.72-
  无形资产摊销1,730,732.41-3,368,021.54-
  长期待摊费用摊销177,349.8-952,845.13-
  处置固定资产、无形资产和其他长期资产的损失-51,320,110.04---
  固定资产报废损失9,338.62-614,061.75-
  公允价值变动损失-4,481,812.46--1,204,788.1-
  财务费用5,280,339.54-15,972,262.68-
  投资损失-605,161.33--8,886,087.59-
  递延所得税-985,179.15--4,290,088.64-
  其中:递延所得税资产减少-812,490.79-1,883,107.58-
    递延所得税负债增加-172,688.36--6,173,196.22-
  存货的减少-20,705,345.58--22,942,933.64-
  经营性应收项目的减少-97,093,253.28--43,451,396.91-
  经营性应付项目的增加10,156,655.44--83,730,639.73-
  其他11,774,558.69-2,611,513.98-
  现金的期末余额256,556,939.47-206,123,263.59-
  减:现金的期初余额206,123,263.59-184,591,943.24-
  现金及现金等价物的净增加额50,433,675.88-21,531,320.35-
公告日期2026-08-152026-04-282026-04-172025-10-28
审计意见(境内)标准无保留意见
TOP↑